Clinical Research Directory
Browse clinical research sites, groups, and studies.
Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.
Sponsor: Nantes University Hospital
Summary
The purpose of this study is to establish the rationale for the practice of performing an oral reintroduction test without previous skin tests in children at low risk of IgE-mediated reaction or drug-induced toxidermia, and to confirm the criteria for a drug reintroduction test could be performed without previous skin tests, without subsequent risk of reaction for the child. The primary endpoint will be the risk of a severe IgE-mediated or delayed hypersensitivity reaction in children who received beta-lactam drug reintroduction protocol prior to skin testing.
Official title: Oral Beta-lactam Drug Reintroduction Protocol, Without Previous Skin Tests, in Children Under 16 Years of Age With a Clinical History That is Not Suggestive of Immunoglobulin E (IgE)-Mediated Anaphylaxis or Toxidermia to Beta-lactams.
Key Details
Gender
All
Age Range
Any - 16 Years
Study Type
OBSERVATIONAL
Enrollment
195
Start Date
2018-09-07
Completion Date
2019-07-19
Last Updated
2026-06-24
Healthy Volunteers
Yes
Locations (1)
Nantes University Hospital
Nantes, Loire-Atlantique, France